Response to the 'Comments on "Cellular Therapies for Treatment of Radiation Injury after a Mass Casualty Incident" (Radiat Res 2017; 188:242-45)' by Drouet et al. (Letters to the Editor, Radiat Res 2017; 188:463)
Radiat Res. 2018 Apr;189(4):446.
doi: 10.1667/RR5LTE.1.
Epub 2018 Feb 6.
1 a Institute of Radioprotection and Nuclear Safety (IRSN), Fontenay-aux-Roses, France.
2 b Previously - RNCP, DAIT, NIAID, NIH, Rockville, Maryland.
3 c Previously - RNCP, DAIT, NIAID, NIH; now National Institute on Aging (NIA), NIH, Bethesda, Maryland.
4 d Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland.